Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine

This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.

Study Overview

• Status: Completed
• Conditions: Pregnancy
• Intervention / Treatment: Drug: medical abortion

Detailed Description

The objective of this pilot study is to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.

• Study Type: Observational
• Enrollment (Actual): 1470

Contacts and Locations

Study Locations

• United States
  • Colorado
    • Denver, Colorado, United States, 80207
      • Planned Parenthood of the Rocky Mountains
  • District of Columbia
    • Washington, District of Columbia, United States, 20815
      • Carafem
  • Georgia
    • Atlanta, Georgia, United States, 30309
      • Carafem
  • Hawaii
    • Honolulu, Hawaii, United States, 96826
      • The University of Hawaii Women's Options Centers
  • Illinois
    • Skokie, Illinois, United States, 60076
      • Carafem
  • Iowa
    • Iowa City, Iowa, United States, 52245
      • Emma Goldman Clinic
  • Maine
    • Augusta, Maine, United States, 04332
      • Maine Family Planning
  • Maryland
    • Chevy Chase, Maryland, United States, 20815
      • Carafem
  • Minnesota
    • Saint Paul, Minnesota, United States, 55114
      • Planned Parenthood Minnesota, North Dakota, South Dakota
  • Montana
    • Billings, Montana, United States, 59102
      • Planned Parenthood of Montana
  • New Mexico
    • New Mexico, New Mexico, United States, 80207
      • Planned Parenthood of the Rocky Mountains
  • New York
    • Jamaica, New York, United States, 11435
      • Choices Women's Medical Center
    • New York, New York, United States, 04332
      • Maine Family Planning
  • Oregon
    • Portland, Oregon, United States, 97212
      • Planned Parenthood Columbia Willamette
    • Portland, Oregon, United States, 97239
      • Oregon Health and Sciences University Women's Health Research Unit
  • Washington
    • Washington, Washington, United States, 97212
      • Planned Parenthood Columbia Willamette
    • Washington, Washington, United States, 97239
      • Oregon Health and Sciences University Women's Health Research Unit

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 10 years to 50 years (Child, Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Women seeking abortion

Description

Inclusion Criteria:

• desires abortion

Exclusion Criteria:

• medically ineligible for procedure

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of participants with adverse events as a measure of safety and tolerability	adverse events	1 year

Collaborators and Investigators

• Sponsor: Gynuity Health Projects
• Investigators: Principal Investigator: Erica Chong, MPH, Gynuity Health Projects

Study record dates

Study Major Dates

• Study Start: March 22, 2016
• Primary Completion (Actual): May 11, 2021
• Study Completion (Actual): May 11, 2021

Study Registration Dates

• First Submitted: July 24, 2015
• First Submitted That Met QC Criteria: July 30, 2015
• First Posted (Estimate): July 31, 2015

Study Record Updates

• Last Update Posted (Actual): February 4, 2022
• Last Update Submitted That Met QC Criteria: February 3, 2022
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: 1031